Intersect ENT Grabs $30 Million for Drug/Device Combo for the Sinuses
2/25/2013 7:51:18 AM
More...
|
Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
1/31/2013 10:17:01 AM
More...
|
Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant
11/6/2012 6:56:22 AM
More...
|
Intersect ENT Release: Groundbreaking Clinical Evidence Demonstrates Benefit of PROPEL Implant for Chronic Sinusitis Patients
6/6/2012 12:26:53 PM
More...
|
Intersect ENT Quadruples Operation Size With Move to Menlo Park
4/18/2012 9:04:16 AM
More...
|
Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes for Sinus Surgery
9/14/2011 6:50:15 AM
More...
|
Intersect ENT Announces U.S. FDA Approval for First Drug Releasing Implant for Chronic Sinusitis Patients
8/15/2011 6:34:45 AM
More...
|
Intersect ENT Closes $30M Series C Financing, Recognized for Clinical Science
11/1/2010 7:22:35 AM
More...
|
Sinexus Changes Name to Intersect ENT, Initiates Pivotal Study
1/7/2010 8:55:51 AM
More...
|